Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Part of paid clinical trials in Rancho Mirage, California.

Sponsor
Pharmatech Oncology
Study ID
NCT00026351
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. Combining chemotherapy with monoclonal antibody therapy may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combining pentostatin and rituximab in treating patients who have non-Hodgkin's lymphoma or chronic lymphocytic leukemia.

Key Dates

Start date
Dec 31, 2000
Status verified
Jul 2002
Completion
Jun 30, 2003

Study Design

Primary purpose
TREATMENT

Locations (5)

FacilityCityStateZIPSite coordinators
Cancer and Blood Institute of the DesertRancho MirageCalifornia92270-
Redding Medical CenterReddingCalifornia96001-
Oncology-Hematology Associates, P.A.ClintonMaryland20735-
North Shore Hematology/Oncology Associates, P.C.East SetauketNew York11733-
Hematology Oncology Associates of Central New York, P.C.SyracuseNew York13210-

Find similar trials in Rancho Mirage, CA

By condition
Leukemia (other)
By specialty
OncologyBlood cancer
By research site
Cancer and Blood Institute of the Desert· Rancho Mirage, CARedding Medical Center· Redding, CAOncology-Hematology Associates, P.A.· Clinton, MDNorth Shore Hematology/Oncology Associates, P.C.· East Setauket, NYHematology Oncology Associates of Central New York, P.C.· Syracuse, NY

Related Studies